These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

361 related articles for article (PubMed ID: 17723872)

  • 1. The world anti-doping program and the primary care physician.
    Hilderbrand RL
    Pediatr Clin North Am; 2007 Aug; 54(4):701-11, x-xi. PubMed ID: 17723872
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Medication, athletes and doping regulations].
    Hartgens F
    Ned Tijdschr Geneeskd; 2008 Aug; 152(33):1844-8. PubMed ID: 18783164
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Medicolegal aspects of doping in sports].
    Pruvost J; Depiesse F
    Ann Readapt Med Phys; 2004 Aug; 47(6):263-73. PubMed ID: 15297116
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rheumatological prescribing in athletes: a review of the new World Anti-Doping Agency guidelines.
    Smith R; Barnsley L; Kannangara S; Mace A
    Rheumatology (Oxford); 2004 Dec; 43(12):1473-5. PubMed ID: 15292526
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The World Anti-Doping Code 2003--consequences for physicians associated with elite athletes.
    Striegel H; Rössner D; Simon P; Niess AM
    Int J Sports Med; 2005 Apr; 26(3):238-43. PubMed ID: 15776342
    [TBL] [Abstract][Full Text] [Related]  

  • 6. World anti-doping regulations for 2005: essential changes for athletes and physicians.
    Pabinger C; Gruber G
    Arch Orthop Trauma Surg; 2006 May; 126(4):286-8. PubMed ID: 16333634
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Doping in sport].
    Schänzer W; Thevis M
    Med Klin (Munich); 2007 Aug; 102(8):631-46. PubMed ID: 17694283
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic Use Exemptions.
    Gerrard D; Pipe A
    Med Sport Sci; 2017; 62():55-67. PubMed ID: 28571022
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Science and the rules governing anti-doping violations.
    Bowers LD
    Handb Exp Pharmacol; 2010; (195):513-31. PubMed ID: 20020378
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Doping control from a global and national perspective.
    Fraser AD
    Ther Drug Monit; 2004 Apr; 26(2):171-4. PubMed ID: 15228160
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A global strategy for prevention and detection of blood doping with erythropoietin and related drugs.
    Cazzola M
    Haematologica; 2000 Jun; 85(6):561-3. PubMed ID: 10870110
    [No Abstract]   [Full Text] [Related]  

  • 12. The status of doping and drug use and the implications for boxing.
    Wadler GI
    Clin Sports Med; 2009 Oct; 28(4):533-43, v-vi. PubMed ID: 19819400
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [World Football Championship 2006--anti-doping regulations].
    Wolfarth B; Graf-Baumann T; Halle M
    MMW Fortschr Med; 2006 Jun; 148(23):41-3. PubMed ID: 16826737
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Harmonization of anti-doping rules in a global context (World Anti-Doping Agency-laboratory accreditation perspective).
    Ivanova V; Miller JH; Rabin O; Squirrell A; Westwood S
    Bioanalysis; 2012 Jul; 4(13):1603-11. PubMed ID: 22831476
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treating the elite athlete: anti-doping information for the health professional.
    Tandon S; Bowers LD; Fedoruk MN
    Mo Med; 2015; 112(2):122-8. PubMed ID: 25958657
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene doping.
    Haisma HJ; de Hon O
    Int J Sports Med; 2006 Apr; 27(4):257-66. PubMed ID: 16572366
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure and Development of the List of Prohibited Substances and Methods.
    Kinahan A; Budgett R; Mazzoni I
    Med Sport Sci; 2017; 62():39-54. PubMed ID: 28571027
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Between medical treatment and performance enhancement: an investigation of how elite athletes experience Therapeutic Use Exemptions.
    Overbye M; Wagner U
    Int J Drug Policy; 2013 Nov; 24(6):579-88. PubMed ID: 23582632
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Doctors belonging to the Senegalese Association of Sport Medicine and doping in sports: survey on knowledge and attitudes].
    Dièye AM; Diallo B; Fall A; Ndiaye M; Cissè F; Faye B
    Sante; 2005; 15(3):167-70. PubMed ID: 16207578
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The use of prohibited substances for therapeutic reasons in athletes affected by endocrine diseases and disorders: the therapeutic use exemption (TUE) in clinical endocrinology.
    Di Luigi L; Pigozzi F; Sgrò P; Frati L; Di Gianfrancesco A; Cappa M
    J Endocrinol Invest; 2020 May; 43(5):563-573. PubMed ID: 31734891
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.